Article
20 May 2024
Large And Unjustified: Second Circuit Clarifies Pleading Requirements In Reverse Payments Cases
AUTHORS CONTENT
Article
17 May 2024
Patent Damages Procedural Fails Keep Coming
Article
23 Apr 2024
The Pleading Standard For Complex Technology? It's Complex.
Article
14 Apr 2024
Nokia And The Burden Of Burdens
Article
05 Apr 2024
ChromaDex Stands Out, But Not In A Good Way
Article
02 Apr 2024
Puma And The Pitfalls Of The "Narrow" Exclusive License
Article
29 Mar 2024
CEMCO Can't Get What It Wants, But Probably What It Needs
Article
25 Mar 2024
Going Global On Polymorphs
Article
11 Mar 2024
No Damages, No Injunction . . . And No Opposition?
Article
11 Mar 2024
Alexa, Again, A Shopping List Is Not A Shopping Cart
Article
26 Feb 2024
Old Tricks/Bad Habits At The Federal Circuit
Article
23 Feb 2024
Doctrinal Lessons On The Doctrine Of Equivalents
Article
22 Feb 2024
Bayer Covenants Not To Sue, Still Has Headache
Article
02 Feb 2024
Hey St. Jude Medical: Playing It Cool Doesn't Always Make You A Fool
Article
17 Jan 2024
Natera And The Power Of The Patent
Article
15 Jan 2024
Alexa: What Is Plain And Ordinary Meaning?
Article
22 Dec 2023
The Inflation Reduction Act's First Potential Impact On Biosimilars
Article
12 Dec 2023
Clarity May Be Around The Corner For Antitrust Scrutiny Of Reverse Payment Settlements
Article
29 Nov 2023
The Federal Circuit Spins A Yarn
Article
22 Nov 2023
The Sewage Of Expert Report Deadlines